Researchers are closing in on a way to deploy photoacoustic imaging such that breast-cancer surgeons can skip the wait on histology tests and, instead, tell cancerous tissue from neighboring noncancerous tissue while the patient is still on the table. 

Breast lesions that physicians can’t feel by palpation are little match for fine-needle aspiration guided by ultrasound, although the procedure’s performance varies somewhat with the age of the patient and the BI-RADS category of the lesion.

A recent Forbes article outlined a study published in the Journal of the American College of Radiology that found none of 479 untreated breast tumors found by screening went away on its own.

Many practicing radiologists share the general public’s sense of befuddlement over state-level breast density legislation and its implications for patient care, at least in New England, according to a study published online May 8 in Academic Radiology.

A leader of the Washington, D.C.-based Black Women’s Health Imperative published an op-ed over the weekend urging passage of a bill in Texas that would require all commercial payers in the Lone Star State to cover digital breast tomosynthesis. 

PET/CT is superior to contrast-enhanced CT when it comes to predicting both progression-free and disease-specific survival in patients with metastatic breast cancer, according to a study published online May 1 in the European Journal of Nuclear Medicine and Molecular Imaging.

Weill Cornell researchers at Memorial Sloan Kettering Cancer Center are recommending the use of PET/CT with the radiotracer fludeoxyglucose (18F-FDG PET/CT) for many patients with newly diagnosed breast cancer.

Nebraska Gov. Pete Ricketts signed Legislative Bill 195 into law today making it the 32nd state to enact mandatory breast density reporting.